Menaquinone 9
(Synonyms: 维生素K2(45),MK-9, Vitamin K2(45)) 目录号 : GC44155
Menaquinone 9(MK-9)是一种维生素K2类似物,已在各种细菌中发现,包括大肠杆菌。
Cas No.:523-39-7
Sample solution is provided at 25 µL, 10mM.
Menaquinone 9 (MK-9) is a vitamin K2 analog found in various bacteria, including Escherichia coli[1, 2]. MK-9 functions as a blood clotting factor and a functional electron-transfer component in nitrate reductase[3]. MK-9 is typically obtained from animal tissues or fermented dairy products such as cheese[4]. High dietary intake of MK-7, MK-8, and MK-9 may help prevent coronary heart disease[5]. Although dietary MK-9 is a precursor to MK-4 in bone tissue, dietary MK-9 supplementation does not affect bone tissue quality or bone mineral density[6].
References:
[1] Crāciun A M, Groenen-van Dooren M, Thijssen H H W, et al. Induction of prothrombin synthesis by K-vitamins compared in vitamin K-deficient and in brodifacoum-treated rats[J]. Biochimica et Biophysica Acta (BBA)-General Subjects, 1998, 1380(1): 75-81.
[2] Koehn J T, Crick D C, Crans D C. Synthesis and characterization of partially and fully saturated menaquinone derivatives[J]. ACS omega, 2018, 3(11): 14889-14901.
[3] Brito F, DeMoss J A, Dubourdieu M. Isolation and identification of menaquinone-9 from purified nitrate reductase of Escherichia coli[J]. Journal of bacteriology, 1995, 177(13): 3728-3735.
[4] Vermeer C, Raes J, Van’t Hoofd C, et al. Menaquinone content of cheese[J]. Nutrients, 2018, 10(4): 446.
[5] Gast G C M, de Roos N M, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease[J]. Nutrition, Metabolism and Cardiovascular Diseases, 2009, 19(7): 504-510.
[6] Liu M, Liu C, Cevallos N, et al. Dietary Menaquinone-9 Supplementation Does Not Influence Bone Tissue Quality or Bone Mineral Density in Mice[J]. bioRxiv, 2025.
Menaquinone 9(MK-9)是一种维生素K2类似物,已在各种细菌中发现,包括大肠杆菌[1, 2]。Menaquinone 9能够作为血栓形成剂和硝酸还原酶中的功能性电子传递成分[3]。Menaquinone 9通常来源于动物组织或者发酵的乳制品,例如奶酪[4]。大量摄入膳食MK-7,MK-8和MK-9,能够预防冠心病[5]。尽管膳食MK-9是骨骼中MK-4的膳食前体,但膳食MK-9补充剂不影响骨组织质量或骨矿物质密度[6]。
| Cas No. | 523-39-7 | SDF | |
| 别名 | 维生素K2(45),MK-9, Vitamin K2(45) | ||
| 化学名 | 2-methyl-3-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaen-1-yl]-1,4-naphthalenedione | ||
| Canonical SMILES | O=C1C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)=C(C)C(C2=CC=CC=C21)=O | ||
| 分子式 | C56H80O2 | 分子量 | 785.2 |
| 溶解度 | 100mg/mL in chloroform | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.2736 mL | 6.3678 mL | 12.7356 mL |
| 5 mM | 254.7 μL | 1.2736 mL | 2.5471 mL |
| 10 mM | 127.4 μL | 636.8 μL | 1.2736 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
